Novelvi®
Noninvasive Prenatal Test (NIPT)
Noninvasive Prenatal Test (NIPT)
Your results are released to your physician through our online medical portal, Revela®. Results for each chromosome tested are reported as either:
Novelvi® is a screening test; results do not stand alone as a diagnosis. Genetic counseling and diagnostic confirmation are necessary prior to making any irreversible pregnancy decision.
In a small percentage of cases, results may be inconclusive. Studies have shown these women may be at increased risk for aneuploidy and should seek counseling about further diagnostic testing.
Progenesis is a San Diego based company that develops and offers genetic testing services for patients throughout their family planning journey. Progenesis was the first company in the U.S. to offer Next Generation Sequencing (NGS) for preimplantation genetic testing. Through optimization of the NGS platform, Progenesis confidently maintains the most accurate testing in the IVF field with the lowest rate of mosaicism.